...
首页> 外文期刊>American Journal of Epidemiology >Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population
【24h】

Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population

机译:在美国人群中肾小球滤过率,白蛋白尿以及心血管和全因死亡率的风险

获取原文
获取原文并翻译 | 示例

摘要

Decreased glomerular filtration rate (GFR) and albuminuria are used in combination to define chronic kidney disease, but their separate and combined effects on cardiovascular and all-cause mortality have not been studied in the general population. The linked mortality file of the Third National Health and Nutrition Examination Survey includes data from 13 years of follow-up (1988–2000) for 14,586 US adults. The authors estimated GFR from standardized serum creatinine levels. Albuminuria was defined by the urinary albumin:creatinine ratio. Incidence rate ratios (IRRs) were adjusted for major cardiovascular disease risk factors and C-reactive protein. Lower estimated GFR was associated with higher risks of cardiovascular and all-cause mortality overall and within every albuminuria category. Likewise, increasing albuminuria was associated with higher risk of estimated GFR overall and within every category. When estimated GFR and albuminuria were examined simultaneously, a 10-ml/minute/1.73 m2 lower estimated GFR (among persons with estimated GFR 60 ml/minute/1.73 m2) was associated with an IRR of 1.29 (95% confidence interval: 1.06, 1.55) for cardiovascular mortality and a doubling of albuminuria was associated with an IRR of 1.06 (95% confidence interval: 1.04, 1.08) for cardiovascular mortality. The authors conclude that moderately decreased estimated GFR and albuminuria independently predict cardiovascular and all-cause mortality in the general population. These data support recent recommendations defining chronic kidney disease and stratifying subsequent risks based on both decreased GFR and albuminuria.
机译:降低肾小球滤过率(GFR)和白蛋白尿可共同定义慢性肾脏病,但尚未在一般人群中研究它们对心血管疾病和全因死亡率的单独和综合影响。第三次全国健康和营养检查调查的关联死亡率文件包括来自13,586名美国成年人的13年随访(1988-2000年)的数据。作者根据标准化的血清肌酐水平估算了GFR。蛋白尿是由尿白蛋白:肌酐比值定义的。调整了主要心血管疾病危险因素和C反应蛋白的发生率比(IRR)。较低的估计GFR与总体上以及每个蛋白尿类别中心血管和全因死亡率的较高风险相关。同样,白蛋白尿的增加与总体上和每个类别内估计GFR的较高风险有关。同时检查估计的GFR和白蛋白尿时,估计的GFR降低10 ml / min / 1.73 m 2 (在估计GFR <60 ml / min / 1.73 m 2 )与心血管疾病死亡率的IRR为1.29(95%置信区间:1.06、1.55)相关,而白蛋白尿量增加一倍与心血管疾病死亡率的IRR为1.06(95%置信区间:1.04、1.08)相关。作者得出的结论是,估计的GFR和蛋白尿的适度降低独立地预测了普通人群的心血管和全因死亡率。这些数据支持最近的建议,这些建议定义了慢性肾脏疾病并基于降低的GFR和白蛋白尿将风险分层。

著录项

  • 来源
    《American Journal of Epidemiology 》 |2008年第10期| p.1226-1234| 共9页
  • 作者单位

    1Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 2Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD 3Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 4Department of Medicine, Division of Nephrology, St. Olav University Hospital, Trondheim, Norway 5Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway 6Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号